Commentary: The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.
作者信息
Chen Leilei, Xie Junxia
机构信息
Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao, China.
出版信息
Front Aging Neurosci. 2023 Jun 19;15:1223421. doi: 10.3389/fnagi.2023.1223421. eCollection 2023.
Abstract
摘要
相似文献
1
Commentary: The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.
Front Aging Neurosci. 2023 Jun 19;15:1223421. doi: 10.3389/fnagi.2023.1223421. eCollection 2023.
2
The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.
Front Aging Neurosci. 2023 Feb 9;15:1116516. doi: 10.3389/fnagi.2023.1116516. eCollection 2023.
3
Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
J Neurol Sci. 2018 Mar 15;386:46-52. doi: 10.1016/j.jns.2018.01.008. Epub 2018 Jan 12.
4
Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Eur J Radiol Open. 2019 Apr 29;6:169-174. doi: 10.1016/j.ejro.2019.04.005. eCollection 2019.
5
Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Neurol India. 2020 Mar-Apr;68(2):278-281. doi: 10.4103/0028-3886.284377.
6
The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.
Quant Imaging Med Surg. 2022 Jul;12(7):3603-3624. doi: 10.21037/qims-21-1090.
7
Anxiety in Parkinson's disease is associated with changes in the brain fear circuit.
Parkinsonism Relat Disord. 2020 Nov;80:89-97. doi: 10.1016/j.parkreldis.2020.09.020. Epub 2020 Sep 19.
8
Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping.
Front Neurol. 2021 Aug 4;12:631210. doi: 10.3389/fneur.2021.631210. eCollection 2021.
9
Brain iron deposition is linked with cognitive severity in Parkinson's disease.
J Neurol Neurosurg Psychiatry. 2020 Apr;91(4):418-425. doi: 10.1136/jnnp-2019-322042. Epub 2020 Feb 20.
10
Characteristics of systemic inflammation and brain iron deposition in Parkinson's disease patients.
Ann Clin Transl Neurol. 2022 Mar;9(3):276-285. doi: 10.1002/acn3.51512. Epub 2022 Jan 25.
引用本文的文献
1
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.
Acta Pharmacol Sin. 2024 Feb;45(2):268-281. doi: 10.1038/s41401-023-01153-z. Epub 2023 Sep 6.
本文引用的文献
1
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis.
Med Res Rev. 2023 Jul;43(4):872-896. doi: 10.1002/med.21939. Epub 2023 Mar 16.
2
The impact of iron deposition on the fear circuit of the brain in patients with Parkinson's disease and anxiety.
Front Aging Neurosci. 2023 Feb 9;15:1116516. doi: 10.3389/fnagi.2023.1116516. eCollection 2023.
3
Calcium Homeostasis in Parkinson's Disease: From Pathology to Treatment.
Neurosci Bull. 2022 Oct;38(10):1267-1270. doi: 10.1007/s12264-022-00899-6. Epub 2022 Jun 21.
4
Neuroimaging Correlates of Substantia Nigra Hyperechogenicity in Parkinson's Disease.
J Parkinsons Dis. 2022;12(4):1191-1200. doi: 10.3233/JPD-213000.
5
Anxiety disorders.
Lancet. 2021 Mar 6;397(10277):914-927. doi: 10.1016/S0140-6736(21)00359-7. Epub 2021 Feb 11.
6
Anxiety in Parkinson's disease: Abnormal resting activity and connectivity.
Brain Res. 2021 Feb 15;1753:147235. doi: 10.1016/j.brainres.2020.147235. Epub 2021 Jan 4.
7
Anxiety in Parkinson's disease is associated with changes in the brain fear circuit.
Parkinsonism Relat Disord. 2020 Nov;80:89-97. doi: 10.1016/j.parkreldis.2020.09.020. Epub 2020 Sep 19.
8
Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease.
Neurosci Bull. 2021 Feb;37(2):275-277. doi: 10.1007/s12264-020-00585-5. Epub 2020 Sep 22.
9
Ferroptosis-Suppressor-Protein 1: A Potential Neuroprotective Target for Combating Ferroptosis.
Mov Disord. 2020 Mar;35(3):400. doi: 10.1002/mds.27990. Epub 2020 Feb 6.
10
Regional iron distribution and soluble ferroprotein profiles in the healthy human brain.
Prog Neurobiol. 2020 Mar;186:101744. doi: 10.1016/j.pneurobio.2019.101744. Epub 2019 Dec 20.
Zotero 插件